Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect

A 15-year-old patient with acute lymphoblastic leukemia and Fusarium infection was treated with voriconazole. She developed asymptomatic bradycardia, QT interval prolongation, and nonsustained, polymorphic ventricular tachycardia, which recurred upon rechallenge with the drug. Voriconazole levels an...

Full description

Saved in:
Bibliographic Details
Main Authors: Alkan, Yoav (Author) , Haefeli, Walter E. (Author) , Burhenne, Jürgen (Author) , Stein, J. (Author) , Yaniv, I. (Author) , Shalit, Itamar (Author)
Format: Article (Journal)
Language:English
Published: 15 September 2004
In: Clinical infectious diseases
Year: 2004, Volume: 39, Issue: 6, Pages: e49-e52
ISSN:1537-6591
DOI:10.1086/423275
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1086/423275
Get full text
Author Notes:Y. Alkan, W.E. Haefeli, J. Burhenne, J. Stein, I. Yaniv, and I. Shalit
Description
Summary:A 15-year-old patient with acute lymphoblastic leukemia and Fusarium infection was treated with voriconazole. She developed asymptomatic bradycardia, QT interval prolongation, and nonsustained, polymorphic ventricular tachycardia, which recurred upon rechallenge with the drug. Voriconazole levels and metabolism were within expected normal values. This non—concentration-dependent, voriconazole-associated ventricular tachycardia mandates cardiac rhythm monitoring during voriconazole treatment.
Item Description:Gesehen am 19.05.2021
Physical Description:Online Resource
ISSN:1537-6591
DOI:10.1086/423275